Chapters

Transcript

Video

What did we learn from pre-clinical animal studies confirming that from an immunobiological, mechanistic perspective, nemvaleukin stimulated CD8+ and natural killer cells while not concommitantly activating the Treg cell axis?


Created by

CMEducation Resources | iQ&A Cytokine Immunotherapy Intelligence Zone

Presenter

Richard Carvajal, MD

Richard Carvajal, MD

Deputy Physician-in-Chief and Director of Medical OncologyRoy J. and Tara Zuckerberg Professor in Medical OncologyNorthwell Health Cancer InstituteLake Success, NY